These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3958761)

  • 1. Stage IIB Hodgkin's disease: the Stanford experience.
    Crnkovich MJ; Hoppe RT; Rosenberg SA
    J Clin Oncol; 1986 Apr; 4(4):472-9. PubMed ID: 3958761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The management of stage I--II Hodgkin's disease with irradiation alone or combined modality therapy: the Stanford experience.
    Hoppe RT; Coleman CN; Cox RS; Rosenberg SA; Kaplan HS
    Blood; 1982 Mar; 59(3):455-65. PubMed ID: 7059665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy.
    Marcus KC; Kalish LA; Coleman CN; Shulman LN; Rosenthal DS; Canellos GP; Mauch PM
    J Clin Oncol; 1994 Dec; 12(12):2567-72. PubMed ID: 7989930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
    Mjaaland I; Ganser D; Freitag EM; Bohndorf W
    Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hodgkin's disease in elderly patients (> or =60): clinical outcome and treatment strategies.
    Kim HK; Silver B; Li S; Neuberg D; Mauch P
    Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):556-60. PubMed ID: 12738333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of prognostic factors after the first relapse of Hodgkin's disease in 187 patients.
    Brice P; Bastion Y; Divine M; Nedellec G; Ferrant A; Gabarre J; Reman O; Lepage E; Fermé C
    Cancer; 1996 Sep; 78(6):1293-9. PubMed ID: 8826953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stage I to IIB Hodgkin's disease: the combined experience at Stanford University and the Joint Center for Radiation Therapy.
    Crnkovich MJ; Leopold K; Hoppe RT; Mauch PM
    J Clin Oncol; 1987 Jul; 5(7):1041-9. PubMed ID: 3598608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiotherapy of early stages Hodgkin's disease. 10 years experience of the Masaryk Memorial Cancer Institute.
    Petera J; Macharová H; Pohanková R; Malír A; Coupek P; Konecný M; Patera J; Pecina J; Drbal J; Koukalová H; Vásová I
    Neoplasma; 2000; 47(2):129-32. PubMed ID: 10985481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of prognostic factors in treatment selection for early-stage Hodgkin's disease.
    Mendenhall NP; Cantor AB; Barré DM; Lynch JW; Million RR
    Am J Clin Oncol; 1994 Jun; 17(3):189-95. PubMed ID: 8192101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis of bulky Hodgkin's disease treated with chemotherapy alone or combined with radiotherapy.
    Bonadonna G; Valagussa P; Santoro A
    Cancer Surv; 1985; 4(2):439-58. PubMed ID: 2430700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors for patients relapsing after radiotherapy for early-stage Hodgkin's disease.
    Roach M; Brophy N; Cox R; Varghese A; Hoppe RT
    J Clin Oncol; 1990 Apr; 8(4):623-9. PubMed ID: 2313331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
    Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stage I-II pediatric Hodgkin's disease: long-term follow-up demonstrates equivalent survival rates following different management schemes.
    Donaldson SS; Whitaker SJ; Plowman PN; Link MP; Malpas JS
    J Clin Oncol; 1990 Jul; 8(7):1128-37. PubMed ID: 2193117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stanford V and radiotherapy for locally extensive and advanced Hodgkin's disease: mature results of a prospective clinical trial.
    Horning SJ; Hoppe RT; Breslin S; Bartlett NL; Brown BW; Rosenberg SA
    J Clin Oncol; 2002 Feb; 20(3):630-7. PubMed ID: 11821442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of preliminary results of involved-field with extended field radiotherapy combined with chemotherapy for early stage Hodgkin's disease].
    Wang WH; Li YX; Song YW; Jin J; Liu YP; Wang SL; Zhou LQ; Liu XF; Yu ZH; Han JZ
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):218-21. PubMed ID: 16875611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
    Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended-field radiotherapy is superior to MOPP chemotherapy for the treatment of pathologic stage I-IIA Hodgkin's disease: eight-year update of an Italian prospective randomized study.
    Biti GP; Cimino G; Cartoni C; Magrini SM; Anselmo AP; Enrici RM; Bellesi GP; Bosi A; Papa G; Giannarelli D
    J Clin Oncol; 1992 Mar; 10(3):378-82. PubMed ID: 1740677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relapse and late complications in early-stage Hodgkin's disease patients with mediastinal involvement treated with radiotherapy alone or plus one cycle of ABVD.
    Enrici RM; Anselmo AP; Donato V; Falchetto Osti M; Santoro M; Tombolini V; Mandelli F
    Haematologica; 1999 Oct; 84(10):917-23. PubMed ID: 10509040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase III randomized intergroup trial of subtotal lymphoid irradiation versus doxorubicin, vinblastine, and subtotal lymphoid irradiation for stage IA to IIA Hodgkin's disease.
    Press OW; LeBlanc M; Lichter AS; Grogan TM; Unger JM; Wasserman TH; Gaynor ER; Peterson BA; Miller TP; Fisher RI
    J Clin Oncol; 2001 Nov; 19(22):4238-44. PubMed ID: 11709567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical presentation and outcome in lymphocyte-predominant Hodgkin's disease.
    Bodis S; Kraus MD; Pinkus G; Silver B; Kadin ME; Canellos GP; Shulman LN; Tarbell NJ; Mauch PM
    J Clin Oncol; 1997 Sep; 15(9):3060-6. PubMed ID: 9294468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.